Your account is not claimed yet. You can sign up with ORCID to claim your account.

Santiago Rello-Varona (Santi Rello-Varona)

Years Active: 2018-2022
Publications (10 Years): 3

Universidad Complutense de Madrid

Universitat Politècnica de València (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Complutense de Madrid Oct 19o 2018

Spain

Associated Lecturer :: Biología Celular

Education History

Universitat Politècnica de València

Spain

MSC

Publications

Daniel José García-Domínguez, Nabil Hajji, Roser López-Alemany, Sara Sánchez-Molina, Elisabet Figuerola-Bou, Francisco J Morón Civanto, Santiago Rello-Varona, Eduardo Andrés León, Adrián Benito, Hector C Keun, Jaume Mora, Òscar Martínez Tirado, Enrique de Álava, Lourdes Hontecillas-Prieto
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1. Oncogene 41 (18) (2022)
Santiago Rello-Varona, Miriam Fuentes-Guirado, Roser López-Alemany, Aida Contreras-Pérez, Núria Mulet-Margalef, Silvia García-Monclús, Oscar M Tirado, Xavier García Del Muro
Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas. Scientific reports 9 (1) (2019)
Silvia Garcia-Monclús, Roser López-Alemany, Olga Almacellas-Rabaiget, David Herrero-Martín, Juan Huertas-Martinez, Laura Lagares-Tena, Piedad Alba-Pavón, Lourdes Hontecillas-Prieto, Jaume Mora, Enrique de Álava, Santiago Rello-Varona, Paloma H Giangrande, Òscar Martínez Tirado
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma. International journal of cancer 143 (5) (2018)

Santiago Rello-Varona.css-eqlu8i{font-size:small;padding-left:4px;} (Santi Rello-Varona)